U.S. Entertainment Stock News

NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Its Recent Share Price Pullback

This article examines whether Natera, at around US$197 a share, still aligns with its underlying worth or whether expectations have already been priced in. The stock has delivered a 31.7% return over the last year and a large 3-year return of about 3.5x, even though the year-to-date move is a 13.8% decline and the last 30 days show a 5.7% decline. Recent coverage around Natera has focused on its position in the pharmaceuticals and biotech space, with investors closely watching how its...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

How Geopolitical Shock to Gold Futures Could Reshape Royal Gold's (RGLD) Investment Narrative

Earlier this week, Royal Gold was caught in a sector-wide reaction as gold futures fell sharply following former President Donald Trump’s ultimatum that the U.S. would strike Iranian power plants if the Strait of Hormuz was not reopened within 48 hours. This episode highlights how sudden geopolitical tensions can quickly shift expectations for companies linked to gold prices, even without any change in their underlying operations. With gold futures under pressure amid these geopolitical...
NYSE:WGO
NYSE:WGOAuto

Winnebago Industries (WGO) EPS Slowdown Tests Bullish Earnings Turnaround Narrative

Winnebago Industries (WGO) has put fresh numbers on the table, with Q1 2026 revenue of US$702.7 million and basic EPS of US$0.20 setting the tone for its latest update. Over recent quarters, revenue has moved between US$620.2 million and US$777.3 million, while basic EPS has ranged from a loss of US$1.01 to a profit of US$0.63. Trailing twelve month EPS sits at US$1.30 on revenue of about US$2.9 billion, which feeds into forecasts for earnings growth and a closer look at how margins are...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Is Zoom’s Deeper AI Fraud Detection Push With Pindrop Altering The Investment Case For Zoom (ZM)?

Earlier in March 2026, Pindrop announced an expanded integration with Zoom Contact Center, embedding real-time AI-driven deepfake detection, voice authentication and fraud risk intelligence into Zoom’s customer experience platform across multiple regulated industries. This move highlights how Zoom is extending its AI capabilities beyond productivity into identity trust and security, positioning its platform more deeply within critical enterprise workflows where fraud prevention is...
NYSE:TPB
NYSE:TPBTobacco

Is It Too Late To Consider Turning Point Brands (TPB) After The Recent 34.9% Pullback?

Wondering whether Turning Point Brands at around US$88 per share still offers value, or if most of the upside is already reflected in the price? This article walks through what the current market tag might be saying. The stock has been volatile recently, with a 34.9% decline over the last 30 days, even though the 1 year return stands at 50.0% and the 3 year return is a very large gain. Recent coverage has focused on how investors are reassessing consumer and tobacco related names, with...
NYSE:STUB
NYSE:STUBEntertainment

Assessing StubHub Holdings (STUB) Valuation After Recent Share Price Strength And Ongoing Losses

StubHub Holdings (STUB) has drawn attention after recent trading, with the share price closing at US$6.87 and showing a return of about 4.2% over the latest session. See our latest analysis for StubHub Holdings. The latest 1 day share price return of 4.3% comes after a weaker patch. The 30 day share price return of 26.2% and year to date share price return of 51.9% both point to fading momentum rather than a quick reversal. If this kind of volatility has you looking at alternatives, it could...
NYSE:KNOP
NYSE:KNOPOil and Gas

KNOT Offshore Partners (KNOP) Profitability Rebuild Challenges Bearish Debt And Decline Narratives

KNOT Offshore Partners (NYSE:KNOP) has reported third quarter FY 2025 revenue of US$96.9 million and basic EPS of US$0.43, alongside net income of US$15.1 million, putting concrete numbers around its recent return to profitability. Over the last few reported periods, revenue has moved from US$74.3 million and EPS of US$0.32 loss in Q2 2024 to US$86.5 million with EPS of US$0.24 in Q2 2025, before reaching the latest US$96.9 million and US$0.43. This progression gives investors a clearer read...
NasdaqGS:BZUN
NasdaqGS:BZUNMultiline Retail

Baozun Q3 Loss Deepens To ¥1.85 EPS And Tests Profit Recovery Narrative

Baozun (NasdaqGS:BZUN) has just posted its FY 2025 third quarter scorecard, with revenue of C¥2,156.2 million and a basic EPS loss of C¥1.85 per share, while trailing twelve month revenue sits at about C¥9.8 billion against a net loss of C¥204.0 million. Over recent quarters, the company has seen revenue range from C¥2,390.9 million in Q2 2024 to C¥2,552.7 million in Q2 2025, with basic EPS shifting between a small profit of C¥0.00 per share in Q4 2024 and losses such as C¥1.48 per share in...
NYSE:V
NYSE:VDiversified Financial

Visa’s Canton Network Role And What It Could Mean For NYSE:V

Visa, ticker NYSE:V, has become the first major payments company to join the Canton Network as a Super Validator. The company is expanding its blockchain and privacy focused digital asset infrastructure for banks and financial institutions. This move is intended to support secure testing and scaling of stablecoin payments, settlement, and treasury activities on a regulated platform. Visa enters this development with an established position in global payments and a current share price of...
NasdaqGS:CPB
NasdaqGS:CPBFood

A Look At Campbell Soup (CPB) Valuation After Recent Share Price Reset

Why Campbell's stock is on investors’ radar Campbell's (CPB) has drawn fresh attention after a roughly 23% decline over the past month, prompting investors to reassess how its current valuation lines up with its earnings profile and branded food portfolio. See our latest analysis for Campbell's. That recent 23% 30 day share price decline, alongside a 1 year total shareholder return of 44% in the red and a 57% total return drop over 3 years, suggests momentum has been fading even as investors...
NYSE:NOAH
NYSE:NOAHCapital Markets

Noah Holdings (NYSE:NOAH) Margin Improvement Challenges Cautious Narratives After FY 2025 Results

Noah Holdings (NYSE:NOAH) has wrapped up FY 2025 with fourth quarter revenue of C¥733.2 million and net income, excluding extra items, of C¥12.8 million, setting the stage for investors to reassess the story at a share price of US$11.33. Over the past few quarters, the company has seen quarterly revenue move from C¥651.9 million in Q4 2024 to C¥614.6 million, C¥629.5 million and C¥632.9 million in the first three quarters of 2025. Over the same period, basic EPS stepped from C¥1.56 in Q4 2024...
NYSE:HLT
NYSE:HLTHospitality

Is It Too Late To Consider Hilton (HLT) After Its Strong Multi Year Share Price Run?

If you are wondering whether Hilton Worldwide Holdings at around US$303 per share offers fair value or is pricing in too much optimism, this breakdown will help you frame the stock through several valuation lenses. The share price closed at US$303.16, with returns of 2.9% over 7 days, a 2.8% decline over 30 days, 3.5% year to date, 29.4% over 1 year, 125.0% over 3 years and 154.0% over 5 years. This raises clear questions about what is already reflected in the price. Recent coverage has...
NasdaqGM:EDAP
NasdaqGM:EDAPMedical Equipment

Persistent €19.6 Million Annual Loss Tests EDAP TMS (NasdaqGM:EDAP) Growth Narrative After Q3 Results

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...
NYSE:WDH
NYSE:WDHInsurance

Waterdrop (NYSE:WDH) Margin Expansion Reinforces Bullish AI Efficiency Narrative

Waterdrop (NYSE:WDH) has put solid numbers on the table for FY 2025 so far, with third quarter revenue of ¥974.9 million and basic EPS of ¥0.44, alongside trailing 12 month EPS of ¥1.40 supported by net income of ¥506.4 million on revenue of ¥3.25 billion. Over recent quarters the company has seen revenue move from ¥676.2 million in Q2 2024 to ¥753.7 million in Q1 2025 and then to ¥974.9 million in Q3 2025. Basic EPS progressed from ¥0.24 in Q2 2024 to ¥0.30 in Q1 2025 and ¥0.44 in Q3 2025,...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

FDA Warning On Anktiva Puts ImmunityBio Growth Story Under Scrutiny

The U.S. FDA has issued a warning letter to ImmunityBio over allegedly false and misleading promotional claims for its bladder cancer drug Anktiva. The letter focuses on how Anktiva has been marketed to healthcare professionals and patients, and requests corrective action from the company. This regulatory action introduces additional marketing and compliance risk for ImmunityBio at a time when its drug portfolio is gaining wider attention. For investors following ImmunityBio, ticker...
NYSE:OXY
NYSE:OXYOil and Gas

Occidental Petroleum (OXY) Is Up 5.9% After Selling OxyChem To Refocus On Core Energy Operations

Occidental Petroleum has completed the sale of its OxyChem chemical business for about US$9.70 billion, directing the proceeds toward debt reduction and sharpening its focus on core oil and gas operations. This portfolio shift, alongside planned 2026 capital investment of US$5.50 billion to US$5.90 billion, marks a meaningful rebalancing of the company toward its highest-priority energy assets. Next, we’ll examine how this OxyChem divestment and debt reduction effort could reshape Occidental...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Assessing Formula One Group (FWON.K) Valuation After Bahrain And Saudi Arabia Race Cancellations

Formula One Group (FWON.K) is facing fresh scrutiny after canceling its Bahrain and Saudi Arabia grands prix because of escalating conflict in the Middle East, removing two high-fee races from its current calendar. See our latest analysis for Formula One Group. The recent cancellations come at a time when Formula One Group’s share price has a 90 day share price return of a 14% decline and a year to date share price return of a 15% decline. Meanwhile, the 5 year total shareholder return of 99%...
NYSE:DHR
NYSE:DHRLife Sciences

Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness?

If you are wondering whether Danaher at around US$187 per share is starting to look appealing, or if the market still has it priced richly, this breakdown will help you frame that question clearly. The stock has recently been under pressure, with returns of a 2.3% decline over 7 days, 11.3% decline over 30 days, 18.8% decline year to date, and 10.5% decline over 1 year, which can change how investors think about both upside potential and risk. Recent coverage has focused on Danaher in the...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Is It Time To Revisit Euronet Worldwide (EEFT) After Its Sharp One Year Share Price Slump?

Wondering whether Euronet Worldwide at a last close of US$67.11 still reflects its true worth, or if the market is mispricing the stock. The share price has been under pressure, with returns of a 0.8% decline over 7 days, a 4.8% decline over 30 days, a 9.4% decline year to date, and a 38.8% decline over the past year, adding to an already weak 3-year and 5-year picture of 38.5% and 51.5% declines. Recent news coverage has focused on Euronet Worldwide's position within the Diversified...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

ParkerVision Appeal Revives Questions Around Qualcomm Licensing And Future Cash Flows

ParkerVision has completed appellate briefing in its patent infringement case against QUALCOMM, challenging a key non infringement argument. The appeal highlights an alleged contradiction in QUALCOMM’s technical position, placing added focus on a prior legal ruling. This development brings renewed attention to QUALCOMM’s legal exposure, an area that has received less coverage than capital returns, competition, and shareholder actions. For investors watching QUALCOMM, ticker NasdaqGS:QCOM,...
NYSE:KBH
NYSE:KBHConsumer Durables

KB Home (KBH) Margin Squeeze In Q1 2026 Reinforces Bearish Profitability Narrative

KB Home Q1 2026: Earnings slip as margins come under pressure KB Home (KBH) opened fiscal 2026 with Q1 revenue of US$1,077.0 million and basic EPS of US$0.53, alongside net income of US$33.4 million as investors weigh how these figures fit into the broader housing cycle. Over recent quarters the company has seen quarterly revenue move from US$1,391.8 million in Q1 2025 to a peak of US$1,999.9 million in Q4 2024 before easing back to US$1,077.0 million in the latest quarter. Quarterly basic...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin PrSM Deal Expands Missile Capacity And Multi Year Visibility

Lockheed Martin (NYSE:LMT) and the U.S. Department of Defense have entered into a major framework agreement to accelerate Precision Strike Missile production. The agreement is intended to expand U.S. missile manufacturing capacity to meet rising domestic and allied demand. The framework may support a multi year commitment, aligning with higher defense priorities and industrial mobilization efforts. For investors watching NYSE:LMT, this new PrSM framework sits against a backdrop of strong...
NYSE:CRM
NYSE:CRMSoftware

Has Salesforce (CRM) Become More Attractive After Its 35% One Year Share Price Decline?

Wondering if Salesforce at around US$181.96 is starting to look like value or still pricing in too much optimism? This article breaks down what the numbers are really saying about the stock. The share price has recently moved, with a 6.4% decline over the last 7 days, a 2.1% gain over 30 days, and returns of 28.3% lower year to date and 34.8% lower over 1 year. This naturally raises questions about whether expectations have reset enough. Recent news coverage has centered on Salesforce's role...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

A Look At LeMaitre Vascular (LMAT) Valuation As Shares Approach Fair Value Estimates

LeMaitre Vascular (LMAT) has caught investor attention after its share price reached a recent close of $109.99, with returns over the past month and past 3 months standing out compared with its longer term record. See our latest analysis for LeMaitre Vascular. That recent move to a share price of $109.99 follows a 30.41% 3 month share price return and a 37.20% year to date share price return, alongside a 141.90% 5 year total shareholder return. Together, these figures indicate momentum...